Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
The aim of our study is to investigate the effects of a combined treatment of alpha-lipoic acid and myoinositol on clinical, endocrine and metabolic features of women affected by PCOS. The study Group included 40 patients treated with a combined therapy of alpha-lipoic acid (800 mg), myoinositol (2000 mg) and folic acid (400 mcg) daily for six months. The investigation includes menstrual pattern, hirsutism score, hormonal assays, oral glucose tolerance test, lipidic profile at baseline and after six months of treatment.
Polycystic Ovary Syndrome|Menstrual Pattern|Hyperandrogenism|Metabolic Features
DRUG: myo-inositol,alpha-lipoic acid and folic acid
Number of cycles in six months of therapy, 6 months
Hirsutism, Ferriman Gallwey score, 6 months|Hyperandrogenism, Testosterone, Androstenedione, free androgen index, 6 months|Insulin response to oral glucose tolerance test, 6 months|Lipidic profile, Total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, 6 months
The aim of our study is to investigate the effects of a combined treatment of alpha-lipoic acid and myoinositol on clinical, endocrine and metabolic features of women affected by PCOS. The study Group included 40 patients treated with a combined therapy of alpha-lipoic acid (800 mg), myoinositol (2000 mg) and folic acid (400 mcg) daily for six months. The investigation includes menstrual pattern, hirsutism score, hormonal assays, oral glucose tolerance test, lipidic profile at baseline and after six months of treatment.